Idebenone
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB09081 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | hepatic porphyria | KG + DL |
| 2 | hepatoportal sclerosis | KG + DL |
| 3 | early-onset familial noncirrhotic portal hypertension | KG + DL |
| 4 | hepatopulmonary syndrome | KG + DL |
| 5 | idiopathic copper-associated cirrhosis | KG + DL |
| 6 | primitive portal vein thrombosis | KG + DL |
| 7 | immune-mediated necrotizing myopathy | KG + DL |
| 8 | osteogenesis imperfecta-retinopathy-seizures-intellectual disability syndrome | KG + DL |
| 9 | antisynthetase syndrome | KG + DL |
| 10 | focal myositis | KG + DL |
| 11 | maternally-inherited mitochondrial myopathy | KG + DL |
| 12 | primary optic atrophy | KG + DL |
| 13 | idiopathic eosinophilic myositis | KG + DL |
| 14 | inflammatory myopathy with abundant macrophages | KG + DL |
| 15 | maternally-inherited mitochondrial dystonia | KG + DL |
| 16 | maternally-inherited Leigh syndrome | KG + DL |
| 17 | juvenile nasopharyngeal angiofibroma (disease) | KG + DL |
| 18 | familial nasal acilia | KG + DL |
| 19 | silent sinus syndrome | KG + DL |
| 20 | genetic otorhinolaryngological malformation | KG + DL |
| 21 | craniorhiny | KG + DL |
| 22 | fetal trimethadione syndrome | KG + DL |
| 23 | maternal hyperthermia induced birth defects | KG + DL |
| 24 | phenobarbital embryopathy | KG + DL |
| 25 | cleft lip/palate-intestinal malrotation-cardiopathy syndrome | KG + DL |
| 26 | neonatal epileptic encephalopathy due to glutaminase deficiency | KG + DL |
| 27 | Leber optic atrophy and dystonia | KG + DL |
| 28 | branchial cleft anomaly | KG + DL |
| 29 | fetal minoxidil syndrome | KG + DL |
| 30 | inborn disorder of phenylalanin or tyrosine metabolism | KG + DL |
| 31 | Bencze syndrome | KG + DL |
| 32 | semicircular canal dehiscence syndrome | KG + DL |
| 33 | idiopathic bilateral vestibulopathy | KG + DL |
| 34 | diabetic embryopathy | KG + DL |
| 35 | mandibulofacial dysostosis-macroblepharon-macrostomia syndrome | KG + DL |
| 36 | tetrahydrobiopterin metabolic process disease | KG + DL |
| 37 | glycogen storage disease due to hepatic glycogen synthase deficiency | KG + DL |
| 38 | indomethacin embryofetopathy | KG + DL |
| 39 | tibial aplasia-ectrodactyly syndrome | KG + DL |
| 40 | familial apolipoprotein C-II deficiency | KG + DL |
| 41 | serpinopathy with toxic serpin polymerization | KG + DL |
| 42 | velo-facial-skeletal syndrome | KG + DL |
| 43 | cocaine embryofetopathy | KG + DL |
| 44 | selective IgG immunodeficiency | KG + DL |
| 45 | C1 inhibitor deficiency | KG + DL |
| 46 | phenylketonuria | KG + DL |
| 47 | aminopterin/methotrexate embryofetopathy | KG + DL |
| 48 | toluene embryopathy | KG + DL |
| 49 | propylthiouracil embryofetopathy | KG + DL |
| 50 | recurrent infections associated with rare immunoglobulin isotypes deficiency | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.